To the Editor:
We were intrigued by the article titled “A Metabolic Map and Artificial Intelligence-Aided Identification of Nasopharyngeal Carcinoma via a Single-Cell Raman Platform,” authored by Xu et al. [1]. In their study, the authors employed a single-cell Raman platform to create a metabolic map encompassing the following: (A) nasopharyngeal carcinoma (NPC) cell lines: They analyzed seven “authenticated” NPC cell lines and one immortalized nasopharyngeal epithelial cell line; (B) Tissue samples: The study included six nasopharyngeal mucosa tissues and seven NPC tissue samples. Through confocal Raman spectroscopic measurements and imaging, the researchers explored altered metabolic processes involving nucleic acids, amino acids, lipids, and sugars. Additionally, they investigated metabolomic profiles using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Notably, the authors proposed that confocal Raman spectroscopy, along with imaging, serves as a highly sensitive diagnostic tool for classifying NPC cells and tissue. While the study provides a wealth of experimental data, it is essential to acknowledge that more than half of the cell lines used in this research have been misidentified as NPC cells, as reported in the Register of Misidentified Cell Lines (version 12, released on January 16, 2023) (Table 1). Out of the seven cell lines analyzed, five exhibit a high degree of genetic overlap with the HeLa short tandem repeat (STR) profile, specifically the CNE1, CNE2, SUNE1, 6-10B, and 5-8F lines. It is acknowledged that the CNE1, CNE2, and SUNE1 lines were initially derived from nasopharyngeal carcinoma. However, due to prolonged culturing and suboptimal laboratory practices, these lines have become contaminated with HeLa cells. Furthermore, the SUNE-1 line serves as the progenitor for the 6-10B and 5-8F lines, which, regrettably, also show genetic similarities to the HeLa STR profile.
The issue of cross-contamination in nasopharyngeal carcinoma cell lines has been a recognized concern since 2008 and has been consistently emphasized in subsequent literature [2, 3]. The latest release from the International Cell Line Authentication Committee (ICLAC), their 12th edition, identifies eight “NPC cell lines” as compromised by cross-contamination [4]. Despite clear genetic evidence indicating the presence of HeLa cell contamination, many research groups focusing on NPC have persisted in utilizing these compromised cell lines to date.
Improving cell line selection and reporting is crucial for research accuracy. However, the prevalence of publications with incorrect cell line data is concerning, as it leads to their continued use and risks the validity of research [5, 6]. Addressing this issue is essential for ensuring reliable scientific outcomes. It is important to establish stringent verification processes and foster a culture of transparency in research practices. Mandatory methods such as short tandem repeat (STR) profiling and DNA fingerprinting are needed to prevent cell line misidentification and safeguard scientific integrity.
The results presented show no significant differences between HeLa-contaminated cell lines and uncontaminated ones. Therefore, the method used does not appear to distinguish between tumor cell lines of various epithelial origins. However, in the study by Xu et al., the presence of HeLa contamination in NPC cell lines does not necessarily invalidate the research findings. Along with the contaminated lines, two uncontaminated NPC cell lines, HK1 (also known as NPC/HK1) and C666-1, were also used. The C666-1 line holds particular importance in NPC research as it consistently carries EBV, reflecting the viral patterns found in most primary NPC biopsies from Chinese patients [7]. The utilization of actual tissue samples further bolsters the study’s validity. Nevertheless, accurate identification of cell lines is crucial to prevent data misinterpretation.
References
Xu J, Chen D, Wu W, Ji X, Dou X, Gao X, et al. A metabolic map and artificial intelligence-aided identification of nasopharyngeal carcinoma via a single-cell Raman platform. Br J Cancer. 2024. https://doi.org/10.1038/s41416-024-02637-3
Chan SY, Choy KW, Tsao SW, Tao Q, Tang T, Chung GT, et al. Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer. 2008;122:2169–71. https://doi.org/10.1002/ijc.23374
Ye F, Chen C, Qin J, Liu J, Zheng C. Genetic profiling reveals an alarming rate of cross-contamination among human cell lines used in China. FASEB J. 2015;29:4268–72. https://doi.org/10.1096/fj.14-266718
American Type Culture Collection Standards Development Organization Workgroup ASN-0002. Cell line misidentification: the beginning of the end. Nat Rev Cancer. 2010;10:441–8. https://doi.org/10.1038/nrc2852
Weiskirchen S, Schröder SK, Buhl EM, Weiskirchen R. A beginner’s guide to cell culture: Practical advice for preventing needless problems. Cells. 2023;12:682. https://doi.org/10.3390/cells12050682
Makowska A, Weiskirchen R. Nasopharyngeal carcinoma cell lines: Reliable alternatives to primary nasopharyngeal cells? Cells. 2024;13:559. https://doi.org/10.3390/cells13070559
Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer. 1999;83:121–6. https://doi.org/10.1002/(sici)1097-0215(19990924)83:1<121::aid-ijc21>3.0.co;2-f
Strong MJ, Baddoo M, Nanbo A, Xu M, Puetter A, Lin Z. Comprehensive high-throughput RNA sequencing analysis reveals contamination of multiple nasopharyngeal carcinoma cell lines with HeLa cell genomes. J Virol. 2014;88:10696–704. https://doi.org/10.1128/JVI.01457-14
Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, et al. Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer. 1980;26:127–32. https://doi.org/10.1002/ijc.2910260202
ICLAC Register of Misidentificed Cell Lines. Available at: https://iclac.org/ last accessed 16 March 2024.
Funding
Open Access funding enabled and organized by Projekt DEAL.
Author information
Authors and Affiliations
Contributions
AM and RW conceived and designed this work. AM and RW wrote the first draft. AM, UK and RW played important roles in interpreting data. AM, UK and RW critically reviewed the final draft. AM and RW supervised the project. All authors have read and agreed to the published version of the manuscript and are accountable for all aspects of the work.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Makowska, A., Kontny, U. & Weiskirchen, R. HeLa cells cross-contaminated nasopharyngeal carcinoma cell lines: Still a common problem. Br J Cancer (2024). https://doi.org/10.1038/s41416-024-02675-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41416-024-02675-x